Loading
Latest filing published 06 Mar 2015 for Teligent, Inc., €2.7M.
No signal scores available.
Filings by Life Sciences Opportunities Fund II LP span 2 companies, the busiest being Bioject Medical Technologies Inc and Teligent, Inc. Between 20 August 2010 and 5 March 2015, the trades on record add up to 16 filings.
Sales make up the whole of the open-market record (6 sales, €41.9M). Since January 2015: no purchases and 2 sales on the market.
The latest filing, published on 6 March 2015, reports an open-market sale of €15.2M in Teligent, Inc. Typically, a trade is published a median of 20 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations